TIAM1 and hepatocellular carcinoma: Initial assessment of the effect of genetic or drug-based targeting of TIAM1 supported its specific requirement in the subset of HCC cells that retain TIAM1 expression and suggest that TIAM1 merits investigation as a potential therapeutic target in a subset of HCC.